HOME >> BIOLOGY >> NEWS
Enzyme mimetic reduces tissue damage in colitis animal study

Study further demonstrates selective, anti-inflammatory properties of small-molecule compounds

St. Louis, MO, December 12, 2001 The estimated 1 to 2 million Americans suffering from inflammatory bowel disease may benefit from a potential new treatment, using small-molecule enzyme mimetics, based on research published in the European Journal of Pharmacology.

The preclinical study conducted by MetaPhore Pharmaceuticals, Inc. of St. Louis, MO and the University of Messina (Italy) showed that a superoxide dismutase (SOD) enzyme mimetic significantly reduced the extent and severity of inflammation and tissue damage to the intestinal wall in an animal model of colitis. Researchers also observed a marked reduction in the diarrhea and body weight loss typical of this disease.

The SOD mimetic, M40403, was also shown to reduce elevated levels of two pro-inflammatory cytokines, tumor necrosis factor alpha (TNF-) and interleukin-1 (IL-1), implicated in the development of inflammatory bowel disease. M40403 is one of a proprietary family of small-molecule SOD mimetics developed by MetaPhore that are designed to selectively remove superoxide, a free radical that, in excess, has been shown to contribute to inflammatory pathways and to regulate cytokine release.

In addition, M40403 reduced the production of adhesion molecules, intercellular adhesion molecule-1 (ICAM-1) and P-selectin, in the intestinal wall of the animals. These adhesion molecules appear to play a major role in the development and persistence of inflammatory bowel disease in humans by promoting infiltration of inflammatory cells (neutrophils) into the intestine wall.

Inflammatory bowel disease includes two specific disorders: Ulcerative colitis, which affects the inner lining of the lower colon, and Crohns disease, which extends into the deeper layers of the intestinal wall. In Crohns disease, the damage to the intestine can be so great that large open
'"/>

Contact: Punnie Donohue
pdonohue@kupperparker.com
314-290-2014
Kupper Parker Communications
12-Dec-2001


Page: 1 2

Related biology news :

1. Enzyme maintaining chromosome ends is linked to bone cancer recurrence, decreased survival
2. Enzyme activation appears key in helping internal clock tell night from day
3. Enzyme fully degrades mad cow disease prion
4. Enzyme revealed that is key to funguss ability to breach immune system
5. Enzyme discovery sheds light on causes of rare disease, cancer
6. Enzyme could overcome industrial bleaching waste problems
7. Enzyme controls good cholesterol
8. Enzyme discovery to benefit homeland security, industry
9. Enzyme could aid cancer fight
10. Enzyme once thought harmful to Alzheimers patients now appears key to future treatment
11. Enzyme studies at Brookhaven Lab may lead to new antiviral agents

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/31/2018)... ... August 30, 2018 , ... CallTower is ... has more than 20-years of telecommunications experience and over ten years in executive leadership. ... was acquired by CallTower in early 2018. , In this new role, ...
(Date:8/29/2018)... ... August 28, 2018 , ... Johanna Dwyer, ... that recognizes women of excellence in the field of intellectual property, and named ... Dwyer Women in IP Award aims to encourage and support women in their ...
(Date:8/26/2018)... ... August 25, 2018 , ... ... impact of a biofield energy treated nutraceutical to reduce inflammation and autoimmune disorders ... function and blood, as well as inflammation. The following data was reported:, ...
Breaking Biology News(10 mins):
(Date:8/29/2018)... ... August 28, 2018 , ... ... spinal implants, announced today the successful completion of a $5.5 million funding round ... Purdue’s Foundry Investment Fund, Commenda Capital, and Ellipsis Ventures. , “Our investment in ...
(Date:8/29/2018)... ... August 28, 2018 , ... CEO and ... a safety study performed on an allogeneic (donor derived) stem cell product for ... (NAVRMA) conference in September. He is also the organizer of Breakout Session ...
(Date:8/26/2018)... LINDA, Calif. (PRWEB) , ... August 23, 2018 ... ... virtual events for tech innovators, engineers, and scientists from around the world, will ... Immunology 2018 will cover an array of industries and disciplines, encompassing various research ...
(Date:8/23/2018)... STATION, N.J. (PRWEB) , ... August 23, 2018 , ... ... University by Visikol Co-Founder Dr. Thomas Villani. Through support from advisors, mentors, the Rutgers ... years later. , Visikol’s path from an idea to a successful biotech company ...
Breaking Biology Technology:
Cached News: